BDC CAPITAL INC. 3
3 · Milestone Pharmaceuticals Inc. · Filed May 8, 2019
Insider Transaction Report
Form 3
BDC CAPITAL INC.
10% Owner
Holdings
- (indirect: See Note 2)
Preferred Shares
→ Common Shares (1,094,004 underlying) Preferred Shares
→ Common Shares (1,094,004 underlying)
Footnotes (3)
- [F1]The Preferred Shares will convert automatically into the number of Common Shares set forth above, without the payment of any additional consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]Consists of 1,094,004 shares held by BDC Capital, Inc., or BDC Capital, and 1,094,004 shares held by GO Capital, s.e.c., a fund for which BDC Capital is the general partner and investment manager. BDC Capital has the power to vote and the power to direct the disposition of all such shares held by itself and Go Capital, s.e.c. BDC Capital's investment in our company is managed by Amplitude Ventures Capital Management Inc., or Amplitude, of which Dion Madsen and Jean-Francois Pariseau serve as partners. Go Capital, s.e.c. is managed by Dominique Belanger, Managing Partner, Co-Investments at BDC Capital. BDC Capital retains the right to approve of certain investment, voting or divestiture decisions proposed by Amplitude, such decisions being approved, depending on their quantum and potential impact, by either senior management at BDC Capital or by BDC Capital's investment committee.
- [F3]The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GO Capital, s.e.c., in which the Reporting Person has no pecuniary interest.